Prognostic Relevance of Pulmonary Arterial Compliance in Patients With Chronic Heart Failure

被引:119
|
作者
Pellegrini, Paolo [1 ]
Rossi, Andrea [1 ]
Pasotti, Michele [2 ]
Raineri, Claudia [2 ]
Cicoira, Mariantonietta [1 ]
Bonapace, Stefano [1 ]
Dini, Frank Lloyd [3 ]
Temporelli, Pier Luigi [4 ]
Vassanelli, Corrado [1 ]
Vanderpool, Rebecca [5 ]
Naeije, Robert [5 ]
Ghio, Stefano [2 ]
机构
[1] Univ Verona, Dept Med, Cardiol Sect, I-37100 Verona, Italy
[2] Fdn IRCCS Policlin S Matteo, Div Cardiol, Pavia, Italy
[3] Univ Pisa, Cardiac Thorac & Vasc Dept, Pisa, Italy
[4] IRCCS, Fdn Salvatore Maugeri, Div Cardiol, Veruno, Italy
[5] Free Univ Brussels, Dept Physiol, Brussels, Belgium
关键词
RIGHT-VENTRICULAR FUNCTION; VASCULAR-RESISTANCE; HYPERTENSION; PRESSURE; DISEASE; CARDIOMYOPATHY; CONSTANT; EXERCISE;
D O I
10.1378/chest.13-1510
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Reduced pulmonary arterial compliance (Ca) is a marker of poor prognosis in idiopathic pulmonary arterial hypertension. We tested the hypothesis that pulmonary arterial Ca could be a predictor of outcome in patients with chronic heart failure (CHF). Methods: We enrolled 306 patients with CHF due to systolic left ventricular dysfunction (sLVD) who underwent a clinically driven right-sided heart catheterization. Pulmonary arterial Ca was measured by the ratio between stroke volume and pulse pressure (SV/PP). The primary end point was cardiovascular death; secondary end point was the composite of cardiovascular death, urgent heart transplantation, and appropriately detected and treated episode of ventricular fibrillation. Results: An inverse relationship was observed between SV/PP and pulmonary vascular resistance, the mean resistance-compliance product (RC-time) being 0.30 +/- 0.2 s. In patients with pulmonary capillary wedge pressure (PCWP), 15 mm Hg, the mean RC- time was 0.34 +/- 0.14 s, and in patients with PCWP >= 15 mm Hg it was 0.28 +/- 0.22 s. Eighty-seven patients died in a follow-up period of 50 +/- 32 months. At receiver operating characteristic curve analysis, the optimal prognostic cutoff point of SV/PP was 2.15 mL/mm Hg. An elevated (. 2.15) SV/PP was more strongly associated with survival than any other hemodynamic variable; it was associated with poor prognosis both in patients with high (P <.003) and in patients with normal pulmonary vascular resistance (P <.005). Conclusions: Pulmonary arterial Ca is a strong prognostic indicator in patients with CHF with sLVD. Most importantly, its prognostic role is retained in patients with normal pulmonary vascular resistance.
引用
收藏
页码:1064 / 1070
页数:7
相关论文
共 50 条
  • [31] Independent Prognostic Value of Pulmonary Diffusing Capacity in Nonsmoking Patients with Chronic Heart Failure
    Nakamura, Kenji
    Kanzaki, Hideaki
    Okada, Atsushi
    Amaki, Makoto
    Takahama, Hiroyuki
    Hasegawa, Takuya
    Sugano, Yasuo
    Yasuda, Satoshi
    Anzai, Toshihisa
    INTERNATIONAL HEART JOURNAL, 2019, 60 (02) : 366 - 373
  • [32] Prognostic value of right heart failure hospitalizations in pulmonary arterial hypertension
    Lujan Talavera, M. LMaria
    Favaloro, L. E.
    Caneva, J. O.
    Klein, F.
    Boughen, R. P.
    Osses, J. M.
    Bertolotti, A. M.
    Favaloro, R. R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 294 - 294
  • [33] Prognostic relevance of sleep apnea syndrome in patients with pulmonary arterial hypertension
    Precek, J.
    Vykoupil, K.
    Kovacik, F.
    Hutyra, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2243 - 2243
  • [34] Prognostic significance of reactive pulmonary hypertension in patients with chronic heart failure listed for elective heart transplantation
    Sobieszczanska-Malek, Malgorzata
    Zielinski, Tomasz
    Piotrowski, Walerian
    Korewicki, Jerzy
    KARDIOLOGIA POLSKA, 2016, 74 (08) : 733 - 740
  • [35] Pulmonary diffusion capacity as prognostic marker in chronic heart failure
    Schaufelberger, M
    EUROPEAN HEART JOURNAL, 2002, 23 (06) : 429 - 431
  • [36] PROGNOSTIC MARKERS FOR THE DEVELOPMENT OF ADVERSE OUTCOMES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CHRONIC HEART FAILURE
    Karoli, N. A.
    Borodkin, A., V
    Kosheleva, N. A.
    Rebrov, A. P.
    KARDIOLOGIYA, 2018, 58 : 39 - 47
  • [37] Pulmonary thromboembolism in patients with chronic heart failure
    Arutyunov, G.
    Rozanov, A.
    Khokhlova, S.
    Rogov, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 55 - 55
  • [38] HEART FAILURE IN PATIENTS WITH CHRONIC PULMONARY EMPHYSEMA
    SANGHVI, LM
    KOTIA, KC
    DISEASES OF THE CHEST, 1963, 44 (01): : 67 - 78
  • [39] Prognostic importance of pulmonary hypertension in patients with heart failure
    Kjaergaard, Jesper
    Akkan, Dilek
    Iversen, Kasper Karmark
    Kjoller, Erik
    Kober, Lars
    Torp-Pedersen, Christian
    Hassager, Christian
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 1146 - 1150
  • [40] Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
    Wu, Yanjuan
    Su, Xiaofen
    Wang, Jingcun
    Zhang, Haojie
    Zeng, Xiangxia
    Zhang, Sun
    Zhang, Nuofu
    Wu, Kang
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (07) : 822 - 823